GPC vs MRKR · P/E 21, rev $12.80B vs rev $751.7K
Genuine Parts Co (GPC) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported GPC revenue for 2026-06-30 was $12.80B. Net income was $416.1M. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
GPC currently screens at market cap $17.60B and trailing P/E 20.7. MRKR currently screens at market cap $25.3M.
Not investment advice. Open the GPC and MRKR stock pages for the full models.
Not investment advice.